Contractile injection system and use thereof
OwnerEva Maria REBROVA, Nicholas TAYLORinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerEva Maria REBROVA, Nicholas TAYLORinventors
Estimating the term…
The invention relates to re-engineering of a natural microbial syringe for loading of effector proteins that are not naturally found as cargo of the specific syringe. The cargo, that is one or more effector protein and proteins required for packing, can be up to 300 kDa and can be proteins such as toxins, therapeutic proteins, and gene modification tools. The re-engineering of the natural syringe result in a contractile injection system that allows packing of large cargo and cargo combinations, such as toxin-chimeras. The system comprises a Conserved Virulence Cassette encoding the syringe structure and is co-expressed with a sequence encoding cargo and a signal peptide. The signal peptide comprises a packing motif that enables packing of cargo into the syringe. The contractile injection system can be used for agricultural purposes as well as for medicinal purposes.
Contractile injection system comprising a Conserved Virulence Cassette controlled by a promoter, said Conserved Virulence cassette comprising structural operons selected from subtypes Ia, Ib, IIa, IIb, IIc, or IId, comprising Open Reading Frames (ORF) encoding a proteinaceous phage tail like syringe structure which functions as a delivery system of cargo, said Conserved Virulence Cassette being co-expressed with an Open Reading Frame controlled by a second promoter encoding a signal peptide and an effector cargo, said signal peptide comprising a packing motif that enables packing of said effector cargo into the syringe, said effector cargo being different from the cargo found in the natural contractile injection system of the Conserved Virulence Cassette and being of up to 300 kDa;
A host selected from a eukaryote cell or a prokaryote cell comprising a Conserved Virulence cassette comprising structural operons selected from subtypes Ia, Ib, IIa, IIb, IIc, or IId, comprising Open Reading Frames (ORF) encoding a proteinaceous phage tail like syringe structure which functions as a delivery system of cargo, said Conserved Virulence Cassette being co-expressed with an Open Reading Frame controlled by a second promoter encoding a signal peptide and an effector cargo, said signal peptide comprising a packing motif that enables packing of said effector cargo into the syringe, said effector cargo being different from the cargo found in the natural contractile injection system of the Conserved Virulence Cassette and being of up to 300 kDa;
Dependencies are inferred from the claim text.